Steven Seedhouse
Stock Analyst at Cantor Fitzgerald
(4.40)
# 1,169
Out of 4,408 analysts
305
Total ratings
41.8%
Success rate
10%
Average return
Main Sectors:
Stocks Rated by Steven Seedhouse
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STO: VICO Vicore Pharma Holding AB (publ) | Initiated Coverage: Buy | kr 33.00 | $10.96 | +201.09% | 1 | Jun 8, 2026 | |
| ALGS Aligos Therapeutics | Maintained: Buy | $20 | $5.11 | +291.39% | 2 | May 28, 2026 | |
| BLTE Belite Bio | Maintained: Buy | $266 | $144.24 | +84.41% | 3 | May 20, 2026 | |
| WVE Wave Life Sciences | Maintained: Buy | $34 → $13 | $6.00 | +116.67% | 9 | May 18, 2026 | |
| IRD Opus Genetics | Maintained: Buy | $15 | $3.92 | +283.14% | 2 | May 13, 2026 | |
| HROW Harrow | Maintained: Buy | $91 → $88 | $38.93 | +126.05% | 6 | May 12, 2026 | |
| PHVS Pharvaris | Reiterated: Buy | $46 | $31.54 | +45.85% | 5 | May 12, 2026 | |
| IFRX InflaRx | Maintained: Buy | $2 → $4 | $1.62 | +146.91% | 27 | May 8, 2026 | |
| CAMP Camp4 Therapeutics | Maintained: Buy | $7 | $3.96 | +76.77% | 7 | May 8, 2026 | |
| ABCL AbCellera Biologics | Initiated Coverage: Buy | $7 | $5.26 | +33.08% | 1 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $105 → $100 | $29.63 | +237.50% | 32 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.56 | +412.82% | 11 | Apr 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 | $22.42 | +42.73% | 5 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $2.80 | +257.14% | 1 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.67 | - | 4 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $23.21 | +72.34% | 2 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | ¥1,130 | $257.00 | +339.69% | 1 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $21 → $22 | $11.66 | +88.68% | 7 | Mar 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $43 | $12.21 | +252.17% | 3 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $49 | $30.60 | +60.13% | 3 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 | $9.06 | +186.98% | 3 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $250 | $287.80 | n/a | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $12.86 | n/a | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $93 → $103 | $124.30 | n/a | 35 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.46 | n/a | 10 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $17 | $3.68 | n/a | 4 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $51 | $82.47 | n/a | 2 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $56 | $18.73 | n/a | 5 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $84 → $77 | $101.00 | n/a | 27 | Oct 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $17 | $0.8128 | n/a | 4 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $35 | $2.86 | n/a | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $94 → $78 | $14.92 | n/a | 15 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $38 | $85.61 | n/a | 1 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $499.76 | n/a | 6 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $5 | $0.167 | n/a | 2 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $59.51 | n/a | 1 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $7.33 | n/a | 11 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.616 | n/a | 10 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $5.83 | n/a | 4 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $198.64 | n/a | 16 | Jul 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $52.61 | n/a | 12 | Jun 13, 2021 |
Vicore Pharma Holding AB (publ)
Jun 8, 2026
Initiated Coverage: Buy
Price Target: kr 33.00
Current: $10.96
Upside: +201.09%
Aligos Therapeutics
May 28, 2026
Maintained: Buy
Price Target: $20
Current: $5.11
Upside: +291.39%
Belite Bio
May 20, 2026
Maintained: Buy
Price Target: $266
Current: $144.24
Upside: +84.41%
Wave Life Sciences
May 18, 2026
Maintained: Buy
Price Target: $34 → $13
Current: $6.00
Upside: +116.67%
Opus Genetics
May 13, 2026
Maintained: Buy
Price Target: $15
Current: $3.92
Upside: +283.14%
Harrow
May 12, 2026
Maintained: Buy
Price Target: $91 → $88
Current: $38.93
Upside: +126.05%
Pharvaris
May 12, 2026
Reiterated: Buy
Price Target: $46
Current: $31.54
Upside: +45.85%
InflaRx
May 8, 2026
Maintained: Buy
Price Target: $2 → $4
Current: $1.62
Upside: +146.91%
Camp4 Therapeutics
May 8, 2026
Maintained: Buy
Price Target: $7
Current: $3.96
Upside: +76.77%
AbCellera Biologics
May 5, 2026
Initiated Coverage: Buy
Price Target: $7
Current: $5.26
Upside: +33.08%
Apr 30, 2026
Maintained: Buy
Price Target: $105 → $100
Current: $29.63
Upside: +237.50%
Apr 14, 2026
Maintained: Buy
Price Target: $8
Current: $1.56
Upside: +412.82%
Apr 7, 2026
Maintained: Buy
Price Target: $32
Current: $22.42
Upside: +42.73%
Apr 7, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $2.80
Upside: +257.14%
Apr 1, 2026
Maintained: Hold
Price Target: n/a
Current: $2.67
Upside: -
Mar 23, 2026
Maintained: Buy
Price Target: $40
Current: $23.21
Upside: +72.34%
Mar 17, 2026
Initiated Coverage: Buy
Price Target: ¥1,130
Current: $257.00
Upside: +339.69%
Mar 12, 2026
Rated: Buy
Price Target: $21 → $22
Current: $11.66
Upside: +88.68%
Feb 25, 2026
Reiterated: Buy
Price Target: $42 → $43
Current: $12.21
Upside: +252.17%
Feb 19, 2026
Reiterated: Buy
Price Target: $42 → $49
Current: $30.60
Upside: +60.13%
Jan 12, 2026
Maintained: Buy
Price Target: $26
Current: $9.06
Upside: +186.98%
Apr 28, 2025
Initiated Coverage: Hold
Price Target: $250
Current: $287.80
Upside: n/a
Dec 11, 2024
Maintained: Buy
Price Target: $22
Current: $12.86
Upside: n/a
Nov 8, 2024
Maintained: Buy
Price Target: $93 → $103
Current: $124.30
Upside: n/a
Nov 4, 2024
Downgraded: Hold
Price Target: n/a
Current: $2.46
Upside: n/a
May 10, 2024
Maintained: Buy
Price Target: $22 → $17
Current: $3.68
Upside: n/a
Apr 18, 2024
Maintained: Buy
Price Target: $24 → $51
Current: $82.47
Upside: n/a
Jan 3, 2024
Maintained: Buy
Price Target: $27 → $56
Current: $18.73
Upside: n/a
Oct 18, 2023
Maintained: Buy
Price Target: $84 → $77
Current: $101.00
Upside: n/a
Jun 23, 2023
Maintained: Buy
Price Target: $25 → $17
Current: $0.8128
Upside: n/a
May 5, 2023
Maintained: Buy
Price Target: $33 → $35
Current: $2.86
Upside: n/a
May 5, 2023
Maintained: Buy
Price Target: $94 → $78
Current: $14.92
Upside: n/a
May 4, 2023
Upgraded: Buy
Price Target: $38
Current: $85.61
Upside: n/a
Dec 19, 2022
Upgraded: Hold
Price Target: n/a
Current: $499.76
Upside: n/a
Dec 7, 2022
Maintained: Buy
Price Target: $15 → $5
Current: $0.167
Upside: n/a
Nov 9, 2022
Maintained: Buy
Price Target: $38
Current: $59.51
Upside: n/a
Aug 10, 2022
Downgraded: Sell
Price Target: n/a
Current: $7.33
Upside: n/a
May 18, 2022
Downgraded: Hold
Price Target: n/a
Current: $0.616
Upside: n/a
Aug 6, 2021
Maintained: Buy
Price Target: $18
Current: $5.83
Upside: n/a
Jul 22, 2021
Maintained: Hold
Price Target: n/a
Current: $198.64
Upside: n/a
Jun 13, 2021
Maintained: Sell
Price Target: n/a
Current: $52.61
Upside: n/a